Financial News
Press Releases about Crispr Therapeutics Ag
![](https://www.marketbeat.com/logos/articles/med_20240710145714_3-beaten-down-pharmaceuticals-with-catalysts-for-h.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240319192215_geron-stock-doubles-after-imetelstat-receives-fda.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240305210324_beam-therapeutics-bolts-higher-on-gene-therapy-lic.jpg)
![](https://www.marketbeat.com/images/MarketBeat-icon-256x256.png)
![](https://www.marketbeat.com/logos/articles/med_20240226142303_bluebird-bio-how-to-play-leaps-options-for-growth.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240225182115_is-crispr-therapeutics-the-nvidia-of-gene-editing.jpg)
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
Via MarketBeat
Topics
Artificial Intelligence
![](https://www.marketbeat.com/logos/articles/med_20240212110357_gene-therapy-why-does-it-cost-millions-for-a-singl.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240214075553_analysts-see-over-50-gains-in-these-2-mid-cap-biot.jpg)
Analysts see over 50% gains in these 2 mid-cap biotech stocks
February 14, 2024
Via MarketBeat
Topics
Artificial Intelligence
![](https://www.marketbeat.com/logos/articles/med_20240125065914_these-5-growth-stocks-are-now-in-buy-ranges.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240122114449_2-gene-editing-stocks-to-keep-on-your-2024-watchli.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240108072132_2-low-priced-gene-therapy-stocks-to-speculate-on.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240101143211_2-gene-editing-stocks-reshaping-hereditary-disease.jpg)
![](https://www.marketbeat.com/logos/articles/med_20231226072941_crispr-therapeutics-sets-sights-on-gene-editing-cu.jpg)
![](https://mms.businesswire.com/media/20231208951733/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20231115290500/en/1093022/5/Vertex_Logo_colorRGB.jpg)
Via Business Wire
![](https://www.marketbeat.com/logos/articles/med_20231108101211_why-you-can-make-vertex-a-buy-on-any-pullback.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230925062932_are-gene-therapy-stocks-the-markets-next-big-winne.jpg)
Are Gene Therapy Stocks The Market's Next Big Winners?
September 25, 2023
Via MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://www.marketbeat.com/logos/articles/med_20230919053331_flee-to-healthcare-stocks-if-recession-rears-its-h.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230712120806_3-biotech-stocks-to-buy-for-long-term-gains.jpg)
![](https://mms.businesswire.com/media/20230609005104/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://mms.businesswire.com/media/20230608005819/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230518072749_vertex-pharmaceuticals-hits-record-high-on-strong.jpg)
![](https://mms.businesswire.com/media/20230402005036/en/1753816/5/CRISPR_Logo.jpg)
![](https://mms.businesswire.com/media/20230324005339/en/1747146/5/Crispr_R-01_%281%29.jpg)
![](https://mms.businesswire.com/media/20221210005006/en/1093022/5/Vertex_Logo_colorRGB.jpg)
![](https://www.marketbeat.com/logos/articles/small_stock-image_599560356_S.jpg)
![](https://www.marketbeat.com/logos/articles/small_stock-image_239974988_S.jpg)
![](https://www.marketbeat.com/images/256x256-marketbeat-icon.png?v=2020)
MarketBeat: Week in Review 8/1 - 8/5
August 06, 2022
Via MarketBeat
![](https://www.marketbeat.com/logos/articles/small_stock-image_9016468_S.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.